Clinical Trials in Dallas

Showing 10001-10020 of 17,468 trials

Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty

NCT00744796

The purpose of this study is to report the early clinical outcomes in patients undergoing Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal edema secondary to corneal endothelial cell dysfunction, and to correlate this clinical data with the latest generation of imaging modalities available for the anterior segment.

Corneal Edema Secondary to Corneal Endothelial Dystrophy

University of Texas Southwestern Medical Center21 participantsStarted Dec 2006

Dallas, Texas, United States

COMPLETEDPhase 1< 1 mile

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

NCT02607774

To determine whether secukinumab can alter the activity of cytochrome P450 (CYP) 3A4 using midazolam as probe substrate in patients with moderate-to-severe plaque psoriasis.

Moderate to Severe Plaque Psoriasis

Novartis Pharmaceuticals25 participantsStarted Dec 2015

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Hot Springs, Arkansas, United States +5 more locations

COMPLETEDPhase 3< 1 mile

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

NCT01371656

This randomized phase III trial studies how well levofloxacin works in preventing infection in young patients with acute leukemia receiving chemotherapy or undergoing stem cell transplant. Giving antibiotics may be effective in preventing or controlling early infection in patients receiving chemotherapy or undergoing stem cell transplant for acute leukemia. It is not yet known whether levofloxacin is effective in preventing infection.

Acute Leukemias of Ambiguous LineageBacterial InfectionDiarrhea+7 more

Children's Oncology Group624 participantsStarted Sep 2011

Little Rock, Arkansas, United States • Downey, California, United States • Duarte, California, United States +81 more locations

Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

Find Trials by Condition in Dallas

Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery

A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.

Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment

Feasibility of a Single-operator Peroral Cholangiopancreatioscopy System (SpyGlass)

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis

Novel INXN-4001 Triple Effector Plasmid in Heart Failure

Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment

A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors